Β-lactamases - Revision history

Aidan at 17:46, 19 September 2024

2024-09-19T17:46:53Z

← Older revision		Revision as of 17:46, 19 September 2024
Line 214:		Line 214:
	== Common β-Lactamases ==		== Common β-Lactamases ==
	{\| class="wikitable"		{\| class="wikitable"
			!β-lactamase[[CiteRef::cantón2008ir]]
	!β-lactamase<ref>Cantón R, Morosini MI, de la Maza OM, de la Pedrosa EG. IRT and CMT beta-lactamases and inhibitor resistance. Clin Microbiol Infect. 2008 Jan;14 Suppl 1:53-62. doi: [https://doi.org/10.1111/j.1469-0691.2007.01849.x 10.1111/j.1469-0691.2007.01849.x]. PMID: [https://pubmed.ncbi.nlm.nih.gov/18154528/ 18154528].</ref>
	!AMX		!AMX
	!AMC		!AMC

2022-09-29T10:04:44Z

Common β-Lactamases

← Older revision		Revision as of 10:04, 29 September 2022
Line 291:		Line 291:
	\|R		\|R
	\|-		\|-
	\|AmpC hyperproduction		\|[[AmpC β-lactamase\|AmpC hyperproduction]]
	\|R		\|R
	\|R		\|R

2022-09-29T10:04:18Z

Common β-Lactamases: fixed the abx abbreviations

2022-09-29T09:59:30Z

@@ Line 211: / Line 211: @@
 *The most common β-lactamase is TEM-1
 *The most common carbapenemases in the US are KPCs, followed by NDM and OXA-48-like carbapenemases
 ==Management==

2022-04-02T16:10:57Z

Management

← Older revision		Revision as of 16:10, 2 April 2022
Line 216:		Line 216:
	*Antibiotic therapy tailored to the resistance pattern		*Antibiotic therapy tailored to the resistance pattern
	*[[Carbapenems]], [[aminoglycosides]], [[fluoroquinolones]], and [[TMP-SMX]] typically work well		*[[Carbapenems]], [[aminoglycosides]], [[fluoroquinolones]], and [[TMP-SMX]] typically work well
			*See also [[Carbapenem-resistant organisms]]

	==Further Reading==		==Further Reading==

2020-09-14T21:05:13Z

Bush-Jacoby Classifications

← Older revision		Revision as of 21:05, 14 September 2020
Line 71:		Line 71:
	***L1 β-lactamase, present in the [[Stenotrophomonas maltophilia]] chromosome		***L1 β-lactamase, present in the [[Stenotrophomonas maltophilia]] chromosome

	=== Bush-Jacoby ~~Classifications~~ ===		===Bush-Jacoby Classification===
	{\| class="wikitable"		{\| class="wikitable"
	! rowspan="2" \|Group		! rowspan="2" \|Group
Line 217:		Line 217:
	*[[Carbapenems]], [[aminoglycosides]], [[fluoroquinolones]], and [[TMP-SMX]] typically work well		*[[Carbapenems]], [[aminoglycosides]], [[fluoroquinolones]], and [[TMP-SMX]] typically work well

	== Further Reading ==		==Further Reading==

	* Updated Functional Classification of β-Lactamases. ''Antimicrob Agents Chemother''. 2010;54(3):969-976. doi: [https://doi.org/10.1128/AAC.01009-09 10.1128/AAC.01009-09]		*Updated Functional Classification of β-Lactamases. ''Antimicrob Agents Chemother''. 2010;54(3):969-976. doi: [https://doi.org/10.1128/AAC.01009-09 10.1128/AAC.01009-09]
	{{DISPLAYTITLE:β-lactamases}}		{{DISPLAYTITLE:β-lactamases}}
	[[Category:Antibiotics]]		[[Category:Antibiotics]]

2020-09-14T21:04:47Z

added Bush-Jacoby classification scheme

2020-09-12T13:08:03Z

2020-09-12T12:35:42Z

← Older revision		Revision as of 12:35, 12 September 2020
Line 40:		Line 40:
	*[[Carbapenems]], [[aminoglycosides]], [[fluoroquinolones]], and [[TMP-SMX]] typically work well		*[[Carbapenems]], [[aminoglycosides]], [[fluoroquinolones]], and [[TMP-SMX]] typically work well

			{{DISPLAYTITLE:β-lactamases}}
	[[Category:Antibiotics]]		[[Category:Antibiotics]]

2020-09-12T12:34:48Z

← Older revision	Revision as of 12:34, 12 September 2020
(No difference)